Norwegian version of this page

Precision medicine tools and interventions

We translate new discoveries and methodology to a clinical setting and integrate prediction and stratification tools in clinical trials to enrich clinical research and improve outcome.

To transform clinical psychiatry into precision medicine (precision psychiatry), it is necessary to improve diagnosis, prediction, and treatment. To address this issue, we are developing novel prediction and stratification tools leveraging multimodal data and artificial intelligence (AI) algorithms for precision psychiatry and improved prevention. 

  • We will improve polygenic and multimodal hazard scores (PHS/MHS), which incorporate multimodal data to predict the time of onset of illness, with initial studies focusing on early detection of Alzheimer’s disease (Desikan et al. 2017, Reas et al. 2023).
  • We will apply new prediction tools, such as digital avatars, to investigate the clinical setting where they will be most relevant for precision psychiatry.
  • We are involved in clinical interventions to test novel therapeutic interventions in psychiatry to improve treatment of mental illness and comorbidities. We have a series of clinical trials, including semaglutide, oxytocin, ketamine and cognitive therapies.

Read more

Desikan RS, Fan CC, Wang Y, Schork AJ, Cabral HJ, Cupples LA, Thompson WK, Besser L, Kukull WA, Holland D, Chen CH, Brewer JB, Karow DS, Kauppi K, Witoelar A, Karch CM, Bonham LW, Yokoyama JS, Rosen HJ, Miller BL, Dillon WP, Wilson DM, Hess CP, Pericak-Vance M, Haines JL, Farrer LA, Mayeux R, Hardy J, Goate AM, Hyman BT, Schellenberg GD, McEvoy LK, Andreassen OA, Dale AM. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score. PLoS Med. 2017 Mar 21;14(3):e1002258. doi: 10.1371/journal.pmed.1002258. 

Reas ET, Shadrin A, Frei O, Motazedi E, McEvoy L, Bahrami S, van der Meer D, Makowski C, Loughnan R, Wang X, Broce I, Banks SJ, Fominykh V, Cheng W, Holland D, Smeland OB, Seibert T, Selbaek G, Brewer JB, Fan CC, Andreassen OA, Dale AM; Alzheimer's Disease Neuroimaging Initiative. Improved multimodal prediction of progression from MCI to Alzheimer's disease combining genetics with quantitative brain MRI and cognitive measures. Alzheimers Dement. 2023 Nov;19(11):5151-5158. doi: 10.1002/alz.13112. 

Osete JR, Akkouh IA, Ievglevskyi O, Vandenberghe M, de Assis DR, Ueland T, Kondratskaya E, Holen B, Szabo A, Hughes T, Smeland OB, Steen VM, Andreassen OA, Djurovic S. Transcriptional and functional effects of lithium in bipolar disorder iPSC-derived cortical spheroids. Mol Psychiatry. 2023 Jul;28(7):3033-3043. doi: 10.1038/s41380-023-01944-0. 

Contact

Published June 24, 2025 2:34 PM - Last modified Sep. 23, 2025 4:13 PM